Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 3/20 | 0.39 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.36 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19974452 | 0.93 | LMNA (0.47) | LMNAALDH1A1TP53MAPTTDP1 | |
| SCHEMBL16374160 | 0.90 | HINT1 (0.41) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL23225541 | 0.90 | NT5E (0.44) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL17359763 | 0.90 | HINT1 (0.41) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL19590406 | 0.90 | HINT1 (0.41) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL20754603 | 0.90 | HINT1 (0.41) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL19777955 | 0.90 | NT5E (0.44) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL24829628 | 0.90 | NT5E (0.44) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL14652919 | 0.90 | NT5E (0.44) | HINT1LMNAALDH1A1TP53MAPT | |
| SCHEMBL930787 | 0.90 | NT5E (0.44) | HINT1LMNAALDH1A1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512860-B1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC (CA) | 2020-11-25 | — | — | EP | disclosed |
| EP-3512860-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB Pharma Inc. (CA) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018049534-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |